Saint Luke’s Clinical Trial Shows Improvements in Patients with Common Genetic Heart Condition

Saint Luke’s Mid America Heart Institute announced the results of a clinical trial that will impact patient care and improve quality of life for patients suffering from the most common genetic heart condition, called hypertrophic cardiomyopathy (HCM). This news comes after 30 years of no new treatments for the condition. Read more…